GLP-1 drugs and artificial intelligence are helping people and organizations, respectively, slim down. And people are reluctant to credit them entirely for the results.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
What Ozempic, AI and layoffs have in common for CEOs
